Chris Butler

Chris Butler has extensive experience in operations and IT within the pharmaceutical industry, currently serving as Director of Operations IT Drug Development at Bristol-Myers Squibb since July 2023. Previously, Chris held multiple roles at Celgene Corp. from 2010 to 2014, including Associate Director of Business Systems and Director, where responsibilities encompassed risk management and medical affairs systems. Prior to Celgene, Chris worked at Atlas Data Systems managing IT solutions, and Merck in various managerial and technical positions, overseeing regulatory compliance systems and project management. Chris holds an MBA and BBA in Management Information Systems from Pace University.